Clinical Trial Update: Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial [Phase 3]

View source ↗

Summary

Adaptive Phase 3 trial assessing optimized COVID-19 vaccination schedules for immunocompromised individuals, including patients with HIV and organ transplantati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Human Immunodeficiency Virus Infection
• Multiple Myeloma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Monash University | Conditions: HIV, Organ Transplantation | Phase 3 | Status: ACTIVE_NOT_RECRUITING